FindMyKOL
Clinical trialNCT01419080CompletedObservational

Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT)

NCT01419080 is an observational study sponsored by Saint Luke's Health System. As of 21 Nov 2026, it is completed. It studies Peripheral Arterial Disease, Quality of Care and 1 more condition. The registry lists an enrollment of 797 participants at 10 sites in 1 country. The registry lists a start date of 31 Oct 2013 and a primary completion date of 31 Dec 2016. One of its registered investigators has a FindMyKOL profile.

SponsorSaint Luke's Health System →Enrollment797Peripheral Arterial DiseaseQuality of CareQuality of Life
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01419080
FieldValue
Registry IDNCT01419080
StatusCompleted
Study typeObservational study
Lead sponsorSaint Luke's Health System
Enrollment797
Registered sites10
Countries1
ConditionsPeripheral Arterial Disease, Quality of Care and Quality of Life
Start31 Oct 2013
Primary completion31 Dec 2016
Study completion31 Dec 2016
Last update posted24 Oct 2025

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

An estimated 8 million individuals in America are affected by peripheral arterial disease (PAD), blockages of the leg arteries that can cause excruciating calf pain when walking. PAD can have a tremendous impact on patients' quality of life. It is also associated with high rates of heart attacks and premature death. While there are a number of treatments, there have been few previous studies that have prospectively examined treatment patterns for PAD or sought to systematically identify opportunities to improve care. Most importantly, there have been no rigorous studies examining the impact of the disease from patients' perspectives - their symptoms, function and quality of life - as a function of different patient characteristics and treatments. The PORTRAIT study (Phase II) will systematically document the treatments and health status (symptom, function and quality of life) outcomes of 840 US patients over the course of one year (assessments at baseline, 3, 6, and 12 months) from 10 centers to address these gaps in knowledge. It will illuminate whether disparities in treatment or health status outcomes exist as a function of patients' age, gender, race, socioeconomic or psychological characteristics. PORTRAIT will substantially elevate the field and identify critical gaps in the way PAD is currently managed, including potential disparities in care, so that the quality of care can be improved.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Connecticut, United States2 sites
  • Bridgeport Hospital

    Bridgeport

  • Yale University

    New Haven

Louisiana, United States1 site
  • Ochsner Health System

    New Orleans

Michigan, United States1 site
  • Saint Joseph Mercy Hospital

    Ann Arbor

Missouri, United States2 sites
  • Saint Luke's Hospital of Kansas City

    Kansas City

  • Truman Medical Center

    Kansas City

North Carolina, United States1 site
  • Duke University Medical Center

    Durham

Ohio, United States1 site
  • Cleveland Clinic

    Cleveland

Rhode Island, United States2 sites
  • Miriam Hospital

    Providence

  • Rhode Island Hospital

    Providence

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichigan: 1 siteMI1New YorkNYMassachusettsMARhode Island: 2 sitesRI2OregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 1 siteOH1PennsylvaniaPANew JerseyNJConnecticut: 2 sitesCT2CaliforniaCANevadaNVWyomingWYNebraskaNEMissouri: 2 sitesMO2KentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth Carolina: 1 siteNC1South CarolinaSCNew MexicoNMOklahomaOKLouisiana: 1 siteLA1MississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01419080

Each answer restates registry values shown on this page.

What is NCT01419080?

NCT01419080 is an observational study sponsored by Saint Luke's Health System. It studies Peripheral Arterial Disease, Quality of Care and 1 more condition.

Who leads NCT01419080?

The registry names John A Spertus, MD, MPH (principal investigator, St. Luke's Hospital, Kansas City, Missouri) and Kim Smolderen, PhD (principal investigator, St. Luke's Hospital, Kansas City, Missouri) as overall officials.

Where does NCT01419080 run?

The registry lists 10 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT01419080 end?

The registry lists a primary completion date of 31 Dec 2016 and a study completion date of 31 Dec 2016. The sponsor last updated the record on 24 Oct 2025.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.